-
My Account
My Account
BSE Live
Jun 18, 16:00Prev. Close
1308.15
Open Price
1320.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jun 18, 15:58Prev. Close
1307.95
Open Price
1320.00
Bid Price (Qty.)
1287.80 (2930)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Thyrocare Technologies (in Rs. Cr.) | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
| Net Sales/Income from operations | 494.62 | 433.20 | 402.91 | 356.32 | 304.39 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 494.62 | 433.20 | 402.91 | 356.32 | 304.39 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 162.53 | 114.92 | 108.46 | 92.20 | 79.22 | |
| Purchase of Traded Goods | 1.09 | 2.25 | 2.33 | 2.41 | 2.56 | |
| Increase/Decrease in Stocks | 0.28 | -0.08 | -0.26 | 0.37 | -0.36 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 58.07 | 48.92 | 43.35 | 35.34 | 32.00 | |
| Depreciation | 30.28 | 31.91 | 26.17 | 20.10 | 18.05 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 101.40 | 94.67 | 94.80 | 81.28 | 75.78 | |
| P/L Before Other Inc., Int., Excpt. Items & Tax | 140.97 | 140.61 | 128.06 | 124.63 | 97.13 | |
| Other Income | 12.43 | 7.73 | 9.95 | 23.00 | 12.24 | |
| P/L Before Int., Excpt. Items & Tax | 153.40 | 148.34 | 138.01 | 147.62 | 109.38 | |
| Interest | 0.87 | 1.85 | 0.61 | 0.44 | 0.27 | |
| P/L Before Exceptional Items & Tax | 152.53 | 146.49 | 137.40 | 147.19 | 109.11 | |
| Exceptional Items | -- | -6.58 | -- | -2.19 | -27.43 | |
| P/L Before Tax | 152.53 | 139.91 | 137.40 | 144.99 | 81.67 | |
| Tax | 39.32 | 52.01 | 52.92 | 51.72 | 38.83 | |
| P/L After Tax from Ordinary Activities | 113.21 | 87.90 | 84.48 | 93.28 | 42.85 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 113.21 | 87.90 | 84.48 | 93.28 | 42.85 | |
| Minority Interest | -- | -- | -- | -- | -- | |
| Share Of P/L Of Associates | -0.07 | 0.51 | 0.66 | -- | -- | |
| Net P/L After M.I & Associates | 113.14 | 88.41 | 85.14 | 93.28 | 42.85 | |
| Equity Share Capital | 52.87 | 52.84 | 52.80 | 53.72 | 53.69 | |
| Reserves Excluding Revaluation Reserves | 371.46 | 310.07 | 378.44 | 389.57 | 354.12 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 21.41 | 16.74 | 15.95 | 17.39 | 7.99 | |
| Diluted EPS | 21.37 | 16.71 | 15.91 | 17.34 | 8.13 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 21.41 | 16.74 | 15.95 | 17.39 | 7.99 | |
| Diluted EPS. | 21.37 | 16.71 | 15.91 | 17.34 | 8.13 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
11.06.2021
Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y
10.05.2021
Thyrocare Techn Standalone March 2021 Net Sales at Rs 139.16 crore, up 48.64% Y-o-Y
10.05.2021
Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
11.06.2021
Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y
10.05.2021
Thyrocare Techn Standalone March 2021 Net Sales at Rs 139.16 crore, up 48.64% Y-o-Y
10.05.2021
Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
